In the context of tendinopathy, IL-1β promotes MMP3 expression by activating the MAPK/NF-κB pathway, whereas TGF-β1 exerts anti-degradation effects by suppressing this pathway (Liao et al., 2021). The gene discussed is IL1B; the disease is disease of the tendon.